The cystic fibrosis lung microbiome

Area of Science:

• Microbiology
• Pulmonology
• Genomics

Background:

• Chronic lower airway bacterial colonization is a primary driver of morbidity and mortality in cystic fibrosis (CF).
• Pseudomonas aeruginosa and Staphylococcus aureus are common CF pathogens, but emerging pathogens like Stenotrophomonas maltophilia and Mycobacterium abscessus are increasing.
• The CF lower airway harbors a complex polymicrobial community, including upper respiratory tract bacteria and obligate anaerobes such as Prevotella.

Purpose of the Study:

• To characterize the composition and dynamics of polymicrobial communities in the lower airways of CF patients.
• To investigate the contribution of the CF microbiome to airway disease.
• To identify new opportunities for CF disease management through microbiome profiling.

Main Methods:

• Utilizing expanded culturing techniques.
• Employing culture-independent molecular methods for microbial community analysis.
• Analyzing the composition and dynamics of polymicrobial communities in CF airways.

Main Results:

• Identification of a complex polymicrobial community in CF airways, extending beyond traditional pathogens.
• Characterization of emerging pathogens and the presence of obligate anaerobes.
• Demonstration of the potential for microbiome profiling to reveal new insights into CF pathogenesis.

Conclusions:

• The CF microbiome is a complex ecosystem with significant implications for airway disease.
• Further research into the CF microbiome may lead to novel therapeutic strategies and improved clinical management.
• Challenges remain in translating microbiome data into routine clinical practice for CF patients.